1h Free Analyst Time
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Drugs In Development, 2022, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.Speak directly to the analyst to clarify any post sales queries you may have.
Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, changes in bowel habits, such as constipation, loss of appetite and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy and radiation therapy.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Ovarian Cancer - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Ovarian Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 12, 190, 218, 11, 27, 367, 85 and 11 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 12, 15, 3, 46 and 13 molecules, respectively.
Ovarian Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Ovarian Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Ovarian Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ovarian Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Ovarian Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Ovarian Cancer (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Ovarian Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Ovarian Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
- Introduction
- Report Coverage
- Ovarian Cancer - Overview
- Ovarian Cancer - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Ovarian Cancer - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Ovarian Cancer - Companies Involved in Therapeutics Development
- Ovarian Cancer - Drug Profiles
- Ovarian Cancer - Dormant Projects
- Ovarian Cancer - Discontinued Products
- Ovarian Cancer - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact the Publisher
- Disclaimer
- Number of Products under Development for Ovarian Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Universities/Institutes, 2022
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Ovarian Cancer - Dormant Projects, 2022
- Ovarian Cancer - Discontinued Products, 2022
- Number of Products under Development for Ovarian Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products by Top 10 Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2Seventy Bio Inc
- 4D Pharma Plc
- 4SC AG
- A2 Biotherapeutics Inc
- A28 Therapeutics Inc
- Aadi Bioscience Inc
- AB Pharma Ltd
- AbbVie Inc
- Abclon Inc
- Abion Inc
- ABL Bio Inc
- ABM Therapeutics Inc
- AC Bioscience SA
- Acrotech Biopharma LLC
- Actuate Therapeutics Inc
- Adagene Suzhou Ltd
- Adaptimmune Therapeutics Plc
- ADC Therapeutics SA
- Adlai Nortye Biopharma Co Ltd
- ADRx Inc
- Advanced Accelerator Applications SA
- Advenchen Laboratories LLC
- Adze Biotechnology Inc
- Affimed GmbH
- Agenus Inc
- AI Therapeutics Inc
- Alaunos Therapeutics Inc
- Alkermes Plc
- Alligator Bioscience AB
- Alloplex Biotherapeutics Inc
- Almac Discovery Ltd
- Alphamab Oncology
- Alpine Immune Sciences Inc
- Alteogen Inc
- Ambrx Biopharma Inc
- Amgen Inc
- Amphivena Therapeutics Inc
- Amplia Therapeutics Ltd
- Angex Pharmaceutical Inc
- AntiCancer Inc
- Anwita Biosciences Inc
- AP Biosciences Inc
- Apexian Pharmaceuticals Inc
- Aphios Corp
- APIM Therapeutics AS
- Apmonia Therapeutics SAS
- Apollomics Inc
- Applied Research using OMIC Sciences SL
- Aprea Therapeutics Inc
- Aprogen Inc
- Aravive Inc
- Argenx SE
- Asana BioSciences LLC
- Ascentage Pharma Group Inc
- Ascentage Pharma Group International
- Ascentawits Pharmaceuticals Ltd
- Asieris Pharmaceuticals Co Ltd
- Aslan Pharmaceuticals Ltd
- Astellas Pharma Inc
- AstraZeneca Plc
- AtlasMedx Inc
- Atossa Therapeutics Inc
- Atrin Pharmaceuticals LLC
- Aucentra Therapeutics Pty Ltd
- Aurealis Therapeutics AG
- Aurigene Discovery Technologies Ltd
- Avacta Life Sciences Ltd
- Avenge Bio Inc
- Avesthagen Ltd
- Avicanna Inc
- Basilea Pharmaceutica Ltd
- Bavarian Nordic AS
- Bayer AG
- BBS NanoTechnology Ltd
- BeiGene Ltd
- Beijing Biostar Technologies Ltd
- Beijing Foreland Pharma Co Ltd
- Beijing FuKangren Bio-pharm Tech Co Ltd
- Beijing Mabworks Biotech Co Ltd
- Beijing Neoantigen Biotechnology Co Ltd
- Beijing Scitech-MQ Pharmaceuticals Ltd
- Bellicum Pharmaceuticals Inc
- BerGenBio ASA
- Bexion Pharmaceuticals LLC
- Bicycle Therapeutics Plc
- Bio-Path Holdings Inc
- Bio-Synectics Inc
- BioAtla Inc
- BioInvent International AB
- Biokine Therapeutics Ltd
- BioMed Valley Discoveries Inc
- BioMoti Ltd
- BioNTech SE
- Biosion Inc
- Biosplice Therapeutics Inc
- Biotheus Inc
- BioVaxys Technology Corp
- Blueprint Medicines Corp
- Boehringer Ingelheim International GmbH
- BoYen Therapeutics Inc
- BridGene Biosciences Inc
- BrightPath Biotherapeutics Co Ltd
- Bristol-Myers Squibb Co
- Calithera Biosciences Inc
- CanBas Co Ltd
- Canget BioTekpharma LLC
- Cardiff Oncology Inc
- Carina Biotech Pty Ltd
- Carisma Therapeutics Inc
- CaroGen Corp
- Carrick Therapeutics Ltd
- Cartherics Pty Ltd
- CAS-Lamvac Biotech Co Ltd
- Catalent Inc
- Catamaran Bio Inc
- Cedilla Therapeutics
- Celdara Medical LLC
- Cellatoz Therapeutics Inc
- Celldex Therapeutics Inc
- Cellid Co Ltd
- Cellis AG
- Cellix Bio Pvt Ltd
- Cello Therapeutics Inc
- Celprogen Inc
- Celtec Inc
- Centrymed Pharmaceutical Inc
- Centurion BioPharma Corp
- CHA Biotech Co Ltd
- Cheetah Cell Therapeutics Co Ltd
- Chengdu Jinrui Foundation Biotechnology Co Ltd
- Chimerix Inc
- Chineo Med Beijing Co Ltd
- Chongqing Pharmaceutical Research Institute Co Ltd
- Chordia Therapeutics Inc
- Chugai Pharmaceutical Co Ltd
- Cible Inc
- Cisen Pharmaceutical Co Ltd
- Clarity Pharmaceuticals Ltd
- Clayton Biotechnologies Inc
- Cloaked Therapeutics LLC
- Clovis Oncology Inc
- CMG Pharmaceutical Co Ltd
- CNS Pharmaceuticals Inc
- Coastar Therapeutics LLC
- Codiak BioSciences Inc
- Coeptis Therapeutics Holdings Inc
- CohBar Inc
- Coherent Biopharma
- Compugen Ltd
- Context Therapeutics Inc
- Cotinga Pharmaceuticals Inc
- Creative Therapeutics GmbH
- CSPC Pharmaceutical Group Ltd
- CureLab Oncology Inc
- Curis Inc
- Cybrexa Inc
- Cyclacel Pharmaceuticals Inc
- Cynvec LLC
- Cyteir Therapeutics Inc
- Cytodyn Inc
- CytomX Therapeutics Inc
- CZ BioMed Corp
- DAE HWA Pharmaceutical Co Ltd
- Daiichi Sankyo Co Ltd
- DeepCure Inc
- DEKK-TEC Inc
- Delta-Fly Pharma Inc
- DevaCell Inc
- Disulfican Ltd
- Dongkook Pharmaceutical Co Ltd
- Dophen Biomed Inc
- Dragonboat Biopharmaceutical (Shanghai) Co Ltd
- Duo Oncology Inc
- Editas Medicine Inc
- Eikonoklastes Therapeutics Inc
- Eisai Co Ltd
- Elevation Oncology Inc
- Eli Lilly and Co
- Ella Therapeutics Ltd
- Ellipses Pharma Ltd
- Elthera AG
- Elucida Oncology Inc
- Enara Bio Ltd
- ENB Therapeutics LLC
- Enlivex Therapeutics Ltd
- Epigene Therapeutics Inc
- EpiThany Inc
- Epizyme Inc
- Epsilogen Ltd
- Epygen Biotech Pvt Ltd
- Essential Biotechnology LLC
- Etirarx LLC
- Eureka Therapeutics Inc
- Evestra Inc
- Exelixis Inc
- ExonanoRNA LLC
- Exscientia Plc
- F-star Therapeutics Inc
- F. Hoffmann-La Roche Ltd
- Falcon Therapeutics Inc
- Fate Therapeutics Inc
- Felicitex Therapeutics Inc
- For-Robin Inc
- Froceth
- Fujifilm Holdings Corp
- Fusion Pharmaceuticals Inc
- Gadeta BV
- GAiA BioMedicine Inc
- Geistlich Pharma AG
- GeneCare Research Institute Co Ltd
- Genekey Biotech Chengdu Co Ltd
- Genelux Corp
- Genentech USA Inc
- Geneos Therapeutics Inc
- Genesen Co Ltd
- Genexine Inc
- Genisphere LLC
- Genmab AS
- GeoVax Labs Inc
- Gilead Sciences Inc
- GLG Pharma SA
- Glycomantra Inc
- GlycoNex Inc
- Glycotope GmbH
- Glysantis Inc
- GlyTherix Ltd
- Gmax Biopharm LLC
- GO Therapeutics Inc
- GP Pharm SA
- Green Cross LabCell Corp
- Greenfire Bio LLC
- Greenwich LifeSciences Inc
- GSK plc
- GT Biopharma Inc
- Guangdong Yinzhu Pharmaceutical Technology Co Ltd
- Guangdong Zhongsheng Pharmaceutical Co Ltd
- Guangzhou BeBetter Medicine Technology Co Ltd
- Guangzhou Sinogen Pharmaceutical Co Ltd
- Guojian Chengnuo Biotechnology Beijing Co Ltd
- H-CYTE Inc
- HaimBio Ltd
- Hangzhou Neoantigen Therapeutics Co Ltd
- Hangzhou Zenshine Pharmaceuticals Co Ltd
- Hanmi Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Harbour BioMed (Guangzhou) Co Ltd
- HCW Biologics Inc
- HDT Bio Corp
- HebeCell Corp
- HEC Pharma Co Ltd
- Helixmith Co Ltd
- Henan Topfond Pharmaceutical TCM Co Ltd
- Hinova Pharmaceuticals Co Ltd
- Horizon Therapeutics Plc
- HRAIN Biotechnology Co Ltd
- Huadong Medicine Co Ltd
- Hubei Soundny Bio-Tech Co Ltd
- Hummingbird Bioscience Pte Ltd
- Hunan Siweikang Therapeutics Ltd
- Hutchison MediPharma Ltd
- I-Mab
- I-Mab Biopharma Co Ltd
- Ideaya Biosciences Inc
- Idera Pharmaceuticals Inc
- Idience Co Ltd
- IGF Oncology LLC
- Ikena Oncology Inc
- Iksuda Therapeutics Ltd
- ImaginAb Inc
- ImCheck Therapeutics SAS
- Immatics NV
- IMMD Inc
- Immix BioPharma Inc
- Immune Biosolutions Inc
- Immune Modulatory Therapies LLC
- Immune Pharmaceuticals Inc
- ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
- Immunitor Inc
- ImmunityBio Inc
- Immuno Cure BioTech Ltd
- Immunocore Holdings Plc
- ImmunoGen Inc
- ImmunSYS Inc
- Immvira Co Ltd
- IMPACT Therapeutics Inc
- Implicyte Inc
- Imugene Ltd
- Imunon Inc
- IMV Inc
- Imvax Inc
- Incyclix Bio LLC
- Incyte Corp
- Indi Molecular Inc
- Infinity Pharmaceuticals Inc
- Inmune Bio Inc
- Innate Pharma SA
- InnoMedica Holding AG
- Innovative Cellular Therapeutics Co Ltd
- Inovio Pharmaceuticals Inc
- Integral Molecular Inc
- Intensity Therapeutics Inc
- Inventiva SA
- Invion Ltd
- InxMed (Beijing) Co Ltd
- IO Biotech Inc
- Ionic Pharmaceuticals LLC
- Iovance Biotherapeutics Inc
- ITM Isotope Technologies Munich SE
- Jacobio Pharmaceuticals Group Co Ltd
- January Therapeutics Inc
- JenKem Technology Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu Kanion Pharmaceutical Co Ltd
- Jivana Biotechnology Inc
- JN Biosciences LLC
- Johnson & Johnson
- Jounce Therapeutics Inc
- JSK Therapeutics Inc
- Kalos Therapeutics Inc
- Karyopharm Therapeutics Inc
- Kenjockety Biotechnology Inc
- KeViRX Inc
- Kiadis Pharma NV
- Kineta Inc
- Kinnate Biopharma Inc
- Kintara Therapeutics Inc
- Kirilys Therapeutics Inc
- Kong's Pharmaceutical
- Kringle Pharma Inc
- KSQ Therapeutics Inc
- Kyowa Kirin Co Ltd
- L&L Biopharma Co Ltd
- L.E.A.F. Pharmaceuticals LLC
- Laekna Therapeutics Shanghai Co Ltd
- Laevoroc Oncology AG
- LaNova Medicines Ltd
- Lantern Pharma Inc
- Lassogen Inc
- LATITUDE Pharmaceuticals Inc
- Le Sun Pharmaceuticals Ltd
- Legend Biotech Corp
- LegoChem Biosciences Inc
- Leucid Bio Ltd
- Lin Bioscience Inc
- Lipac Oncology LLC
- Lipocure Ltd
- Lipomedics Ltd
- LipoSeuticals Inc
- Livzon Pharmaceutical Group Co Ltd
- Lixte Biotechnology Holdings Inc
- Luminus Biosciences Inc
- Lycera Corp
- Lyvgen Biopharma Ltd
- Machavert Pharmaceuticals LLC
- MacroGenics Inc
- MAIA Biotechnology Inc
- Marker Therapeutics Inc
- MaxiVAX SA
- MedAnnex Ltd
- MedGene Therapeutics Inc
- MediaPharma SRL
- Medicenna Therapeutics Corp
- MediciNova Inc
- MediGene AG
- Meditope Biosciences Inc
- Medolife Rx Inc
- Mendus AB
- Merck & Co Inc
- Merck KGaA
- Mersana Therapeutics Inc
- MicroQuin Ltd
- Midissia Therapeutics Inc
- Millennium Pharmaceuticals Inc
- Mina Therapeutics Ltd
- Minerva Biotechnologies Corp
- Mirati Therapeutics Inc
- Modra Pharmaceuticals BV
- Molecular Partners AG
- Molecular Templates Inc
- Moleculin Biotech Inc
- Monopar Therapeutics Inc
- Monte Rosa Therapeutics Inc
- MorphoSys AG
- Mosaic ImmunoEngineering Inc
- Multitude therapeutics Inc
- Mundipharma EDO GmbH
- Myeloid Therapeutics Inc
- N1 Life Inc
- Nammi Therapeutics Inc
- Nanjing Bioheng Biotech Co Ltd
- Nanjing Blue Shield Biotech Co Ltd
- Nanjing CART Medical Technology Co Ltd
- Nanjing KAEDI Biotech Inc
- Nanjing Sanhome Pharmaceutical Co Ltd
- Nanogenics Ltd
- NanoVation Therapeutics Inc
- Nemucore Medical Innovations Inc
- Neomics Pharmaceuticals LLC
- Neosome Life Sciences LLC
- NewBio Therapeutics Inc
- NextCure Inc
- NGM Biopharmaceuticals Inc
- Ningbo Wenda Pharmaceutical Technology Co Ltd
- Northlake International LLC
- NovaRock Biotherapeutics Inc
- Novartis AG
- Noviga Research AB
- Novita Pharmaceuticals Inc
- NUAgo Therapeutics Inc
- Nuvalent Inc
- Nuvation Bio Inc
- Nuvectis Pharma Inc
- OBiO Technology (Shanghai) Corp Ltd
- Ocellaris Pharma Inc
- Omeros Corp
- Omideon Ltd
- OmniCyte Ltd
- Ona Therapeutics SL
- OncoC4 Inc
- Oncodesign SA
- Oncolyze Inc
- Oncomatryx Biopharma SL
- Onconic Therapeutics Co Ltd
- OncoOne Research & Development GmbH
- OncoQuest Inc
- OncoResponse Inc
- OncoTartis Inc
- OncoTherapy Science Inc
- Oncoxx Biotech Srl
- OneThree Biotech Inc
- ONK Therapeutics Ltd
- Ono Pharmaceutical Co Ltd
- Onxeo SA
- OPKO Health Inc
- Opna Bio SA
- Orano Med LLC
- ORCA Therapeutics BV
- Oregon Therapeutics
- Orgenesis Inc
- Orpheus Therapeutics Inc
- OS Therapies LLC
- Oxford BioTherapeutics Ltd
- Oxford Vacmedix UK Ltd
- Pact Pharma Inc
- Pai Life Sciences Inc
- Palisades Therapeutics
- Palleon Pharmaceuticals Inc
- Pamdeca LLC
- Pan Cancer T BV
- Panbela Therapeutics Inc
- Pantarhei Oncology BV
- Papyrus Therapeutics Inc
- Parasol Biotech Co Ltd
- Patrys Ltd
- PDS Biotechnology Corp
- PENAO Pty Ltd
- PEP-Therapy SAS
- PepVax Inc
- Perseus Proteomics Inc
- Pfizer Inc
- Phanes Therapeutics Inc
- Pharma Mar SA
- PharmAust Ltd
- Pharos iBio Co Ltd
- Pheast Therapeutics Inc
- Phi Pharma SA
- Phio Pharmaceuticals Corp
- pHion Therapeutics Ltd
- PI Therapeutics Ltd
- Pinotbio Inc
- Pionyr Immunotherapeutics Inc
- Plus Therapeutics Inc
- Portage Biotech Inc
- Poseida Therapeutics Inc
- Precigen Inc
- Prelude Therapeutics Inc
- Prescient Therapeutics Ltd
- Prestige BioPharma Ltd
- Primetime Life Sciences LLC
- PRISM Pharma Co Ltd
- Processa Pharmaceuticals Inc
- Proen Therapeutics Co Ltd
- ProLynx LLC
- Promontory Therapeutics Inc
- Propanc Biopharma Inc
- Protheragen Inc
- Provectus Biopharmaceuticals Inc
- Providence Therapeutics Inc
- PsiOxus Therapeutics Ltd
- Puma Biotechnology Inc
- Purple Biotech Ltd
- Pyxis Oncology Inc
- Qilu Pharmaceutical Co Ltd
- Qu Biologics Inc
- Quadriga BioSciences Inc
- Que Oncology Inc
- QureBio Ltd
- Qwixel Therapeutics LLC
- R-Pharm
- Race Oncology Ltd
- Radiopharm Theranostics Ltd
- Rain Therapeutics Inc
- Recordati SpA
- Recursion Pharmaceuticals Inc
- Regeneron Pharmaceuticals Inc
- Relay Therapeutics Inc
- RemeGen Co Ltd
- Repare Therapeutics Inc
- Rescue Therapeutics Inc
- Reven Holdings Inc
- Revere Pharmaceuticals Inc
- Rhizen Pharmaceuticals SA
- Roivant Sciences Inc
- RS Oncology LLC
- RS Research
- Rubicon Biotechnology Inc
- Sagimet Biosciences Inc
- Salarius Pharmaceuticals Inc
- Sanofi
- Sapvax LLC
- Sathgen Biotech
- Sator Therapeutics LLC
- Scancell Holdings Plc
- Scandion Oncology AS
- Scholar Rock Inc
- Seagen Inc
- SELLAS Life Sciences Group Inc
- Senhwa Biosciences Inc
- Sequoia Vaccines Inc
- Shandong Boan Biotechnology Co Ltd
- Shanghai Affinity Biomedical Technology Co Ltd
- Shanghai Cell Therapy Group Co
- Shanghai De Novo Pharmatech Co Ltd
- Shanghai Escugen Biotechnology Co Ltd
- Shanghai Fosun Pharmaceutical (Group) Co Ltd
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
- Shanghai GeneChem Co Ltd
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Huilun Life Science & Technology Co Ltd
- Shanghai Jiatan Pharmaceutical Technology Co Ltd
- Shanghai Miracogen Inc
- Shanghai Novamab Biopharmaceuticals Co Ltd
- Shanghai Pharmaceutical Group Co Ltd
- Shanghai Yihao Biotechnology Co Ltd
- Shanghai Yingli Pharmaceutical Co Ltd
- Shanghai Yuansong Biotechnology Co Ltd
- Shenzhen Chipscreen Biosciences Co Ltd
- Shorla Pharma Ltd
- Sichuan Kangdesai Medical Technology Co Ltd
- SideROS
- Sihuan Pharmaceutical Holdings Group Ltd
- Simcha Therapeutics Inc
- siRNAgen Therapeutics Corp
- SL Bigen Co Ltd
- SN BioScience
- Sonoval LLC
- Soricimed Biopharma Inc
- Sorrento Therapeutics Inc
- SOTIO Biotech AS
- Sphaera Pharma Pte Ltd
- Splash Pharmaceuticals Inc
- SpringWorks Therapeutics Inc
- Starpharma Holdings Ltd
- Statera Biopharma Inc
- Stingthera Inc
- Sumitomo Dainippon Pharma Oncology, Inc
- Sun Pharma Advanced Research Company Ltd
- Sunshine Biopharma Inc
- Suntec Medical (Taiwan) Inc
- SuperTrans Medical Ltd
- Supratek Pharma Inc
- Susavion Biosciences Inc
- Sutro Biopharma Inc
- Suzhou Immunofoco Biotechnology Co Ltd
- Suzhou Innovative Biomaterials & Pharmaceutics Co Ltd
- Suzhou Maximum Bio-tech Co Ltd
- Suzhou Neupharma Co Ltd
- Suzhou Stainwei Biotech Inc
- Suzhou Zerun New Drug Research and Development Co Ltd
- Synergys Biotherapeutics Inc
- Synthekine Inc
- Syros Pharmaceuticals Inc
- Systimmune Inc
- T-Cure Bioscience Inc
- Tactiva Therapeutics LLC
- TAE Life Sciences LLC
- Tagworks Pharmaceuticals BV
- Taiho Pharmaceutical Co Ltd
- Tailored Therapeutics LLC
- Takeda Pharmaceutical Co Ltd
- Takis Srl
- Tango Therapeutics Inc
- Targovax ASA
- Tarveda Therapeutics Inc
- Tasly Pharmaceutical Group Co Ltd
- TCR Cure Biopharma Technology Co Ltd
- TCR2 Therapeutics Inc
- Tempest Therapeutics Inc
- Temple Therapeutics BV
- Teon Therapeutics Inc
- Tetranov International Inc
- Theolytics Ltd
- Theranano LLC
- TheraTarget Inc
- Theratechnologies Inc
- Thetis Pharmaceuticals LLC
- TILT Biotherapeutics Ltd
- Tmunity Therapeutics Inc
- ToolGen Inc
- TORL Biotherapeutics LLC
- TOT Biopharm Co Ltd
- TRACON Pharmaceuticals Inc
- Tradewind BioScience Inc
- Transcenta Holding Ltd
- Transgene SA
- TransGenex Nanobiotech Inc
- Treos Bio Ltd
- Triumvira Immunologics Inc
- TVAX Biomedical Inc
- TYK Medicines Inc
- Tyme Inc
- UBI Pharma Inc
- UbiVac Inc
- United Immunity Co Ltd
- Up Therapeutics Inc
- UTC Therapeutics Inc
- UWELL Biopharma Inc
- VacV Biotherapeutics Ltd
- ValiRx Plc
- Vaxil Bio Therapeutics Ltd
- Vectorite Biomedical Inc
- Venus Remedies Ltd
- Verastem Inc
- Verismo Therapeutics
- Vertex Pharmaceuticals Inc
- Veru Inc
- Vincerx Pharma Inc
- Vivesto AB
- VM Discovery Inc
- Voltron Therapeutics Inc
- Wuhan YZY Biopharma Co Ltd
- XEME BioPharma Inc
- Xencor Inc
- Xiangxue Life Sciences
- Xilio Therapeutics Inc
- XinThera Inc
- XuanZhu Biological Technology Co Ltd
- Xynomic Pharmaceuticals Holdings Inc
- Yooyoung Pharm Co Ltd
- Zenith Epigenetics Ltd
- Zhejiang Hisun Pharmaceutical Co Ltd
- Zhejiang Landun Pharmaceutical Co Ltd
- Zhuhai Beihai Biotech Co Ltd
- Zhuhai GRIT biotechnology Inc
- ZielBio Inc
- Zy Therapeutics Inc
- Zylem Biosciences Inc
- Zymeworks Inc
